Health Trials

Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device.

ConditionsMild Cognitive Impairment (MCI)Early Stages of Cognitive DeclineAlzheimer's Disease DementiaAlzheimer's Disease DiagnosisAlzheimer's Disease and Related DementiasParkinson's DiseaseParkinson's Disease (PD)Parkinson's Disease With Wearing-off Motor FluctuationsDementia (Diagnosis)Dementia MCI (Mild Cognitive Impairment)
Trial statusNot yet recruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age55+
SponsorNoah Tech, Corp.

About this trial

This study aims to evaluate the efficacy of community-based early detection and targeted interventions, including stem cell therapy and wearable non-invasive brain-computer interface (BCI) devices, for Mild Cognitive Impairment (MCI) in adults aged 55 years and older residing in U.S. urban and suburban communities. Primary objectives include assessing improvements in MCI detection rates, cognitive outcomes, and progression delay compared to standard care.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Structured wellness care
  • Wearable brain-computer interface devices
  • Stem Cell Therapy - Experimental
  • Control - Placebo Comparator

Treatment groups

600 Participants
are divided into 4 treatment groups

Sponsors and collaborators

Noah Tech, Corp.

Lead sponsor

Source ClinicalTrials.gov